The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer
| Autor: | Francis, K.E., Kim, S.I., Friedlander, M., Gebski, V., Ray-Coquard, I., Clamp, A., Penson, R.T., Oza, A., Perri, T., Huzarski, T., Martin-Lorente, C., Cecere, S.C., Colombo, N., Ataseven, B., Fujiwara, K., Sonke, G., Vergote, I., Pujade-Lauraine, E., Kim, J.-W., Lee, C.K. |
|---|---|
| Zdroj: | In Annals of Oncology June 2022 33(6):593-601 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|